GlassScriptPhysician profile
Alexandra Rose Schoonover
NPI 1043879570
$303.36
in general payments reported to CMS, 2019-2025
8 companies · $68.99 in 2025
The $68.99 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.47 · 2023: $109 · 2024: $99.63 · 2025: $68.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $59.61 | 2023 | Rexulti |
| Merck Sharp & Dohme LLC | $50.35 | 2024 | Delstrigo, Pifeltro, Dificid |
| Exact Sciences Corporation | $49.28 | 2024 | Cologuard Collection Kit |
| Viiv Healthcare Company | $44.94 | 2025 | Cabenuva |
| Lundbeck LLC | $25.75 | 2023 | Rexulti |
| Sunovion Pharmaceuticals INC. | $25.47 | 2021 | |
| Axsome Therapeutics, INC. | $24.05 | 2025 | Auvelity |
| Alkermes, INC. | $23.91 | 2023 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Schoonover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.